All Opioids stories

MLB weighs new opioid testing policy for players

Tyler Skaggs died at age 27 in July from opioid-related causes. Photo: Mike Carlson/Getty Images

Major League Baseball players could be randomly tested for the first time for opioids like oxycodone and fentanyl as the sport grapples with how to address the opioid epidemic, the Wall Street Journal reports.

Why it matters: Professional athletes, who are especially prone to injury, risk greater exposure and addiction to opioids due to pain management. The discussions between the league and its players' union were prompted by the July death of Los Angeles Angels pitcher Tyler Skaggs, who had oxycodone, fentanyl and alcohol in his system.

Go deeper: Where the major sports leagues stand on weed

Keep ReadingArrowNov 27, 2019

More opioid companies facing criminal probes

Oxycodone pills. Photo: Eric Baradat/AFP via Getty Images

Several opioid manufacturers and drug distributors are facing criminal investigations from the Department of Justice about whether they intentionally skirted federal law by not monitoring the flow of potent painkiller pills, the Wall Street Journal reports.

Why it matters: Purdue Pharma has already been ensnared in criminal probes, and now federal prosecutors are casting a wider net to determine the level of alleged wrongdoing that has resulted in tens of thousands of overdose deaths.

Go deeperArrowUpdated Nov 27, 2019

Mental health coverage is getting worse

Data: Mental Health Treatment and Research Institute; Chart: Axios Visuals

As suicide and overdose rates have increased, mental health and substance abuse insurance coverage has gotten worse, according to a new Milliman report commissioned by the Mental Health Treatment and Research Institute.

Why it matters: Behavioral health treatment often isn't covered by insurance, and it's often unaffordable — including for patients for whom treatment is a matter of life and death.

Go deeperArrowNov 21, 2019 - Health

Oklahoma judge lowers Johnson & Johnson's opioid payout

Photo: Mark Ralston/AFP via Getty Images

Johnson & Johnson will only have to pay $465 million for its role in the state's opioid crisis as of Friday, instead of the original $572 million judgment, after the Oklahoma judge overseeing the case admitted he made a math error in the abatement plan.

The big picture: Oklahoma maintained its verdict that J&J created a public nuisance by falsely promoting its opioids as safe and necessary, and J&J still plans on appealing the decision, despite the lower amount.

Go deeper: Johnson & Johnson's legal bills keep mounting

Keep ReadingArrowNov 15, 2019

Walgreens' outsized role in the opioid epidemic

Photo: Joe Raedle/Getty Images

Walgreens handled nearly one in five oxycodone and hydrocodone pills that were shipped to pharmacies between 2006 and 2012, as the opioid epidemic worsened, the Washington Post reports.

Between the lines: Walgreens is one of the companies being sued by thousands of communities across the country in federal court.

Go deeperArrowNov 8, 2019

Cardinal Health sets aside $5.6 billion for opioid lawsuits

Photo: Igor Golovniov/SOPA Images/LightRocket via Getty Images

Drug distributor Cardinal Health registered a $5.6 billion pre-tax charge in the third quarter, saying the company "agreed in principle to a global settlement" with states, cities and others to pay that amount over 18 years to resolve the opioid cases.

Why it matters: Cardinal is the first company to set aside billions of dollars in preparation for any national opioids settlement, even though a definitive settlement agreement has not been finalized.

The massive opioids lawsuit is unlikely to be resolved soon

Oxycodone. Photo: Education Images/Universal Images Group via Getty Images

A settlement resolving all of the pending lawsuits over the opioid crisis is "unlikely in the near term," according to state attorneys general and attorneys involved in the litigation brought by communities, the Washington Post reports.

Why it matters: That means that it could be a long time before places still plagued by the opioid epidemic receive substantial new funding to address it.

Go deeperArrowOct 31, 2019

Today's health problems are tomorrow's health crises

Data: National Health and Nutrition Examination Survey; Chart: Andrew Witherspoon/Axios

The health troubles we're seeing now — especially among young people — will continue to strain the system for years and even decades to come.

The big picture: Rising obesity rates now will translate into rising rates of type 2 diabetes and heart disease. The costs of the opioid crisis will continue to mount even after the acute crisis ends. And all of this will strain what’s already the most expensive health care system in the world.

Go deeperArrowOct 31, 2019 - Health

We're all paying for the opioid epidemic

Photo: John Moore/Getty Images

The ongoing opioid crisis cost $696 billion in 2018 and more than $2.5 trillion between 2015 and 2018, according to a new estimate by the White House Council of Economic Advisers.

Why it matters: Much of this cost is attributable to lives lost to opioids, but a good amount of it is borne by state and federal governments — and thus taxpayers. Meanwhile, opioid litigation settlement talks are homing in on payouts nowhere near this amount.

Go deeperArrowOct 29, 2019

The opioids legal battles rage on

Illustration: Lazaro Gamio/Axios

The federal opioids litigation took a step closer to resolution yesterday when major drug companies settled with 2 Ohio counties just before a trial was scheduled to begin.

Yes, but: States, municipalities and the companies being sued are still hashing out a global resolution to the thousands of lawsuits pending across the country.

Go deeperArrowOct 22, 2019